Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Feb;63(2):261–264. doi: 10.1038/bjc.1991.61

A proposal for short-term quality control in breast cancer screening.

A L Verbeek 1, M C Van den Ban 1, J H Hendriks 1
PMCID: PMC1971772  PMID: 1997104

Abstract

Current proposals for a monitoring and evaluation system in breast cancer screening programmes focus on mortality reduction. Here emphasis is laid on the prevention of too high a number of false-positive screening results, i.e. no subsequent demonstration of malignancy. By comparing the specificity of the screening test, the positive predictive value and the detection rate with reference values, the screening performance can be measured in a very early phase of the programme, even before the registration results on interval cancers become available. The proposed average reference values for the first screening round are 99.2%, 40% and 5.4/1000, respectively. Measures specifically for the age groups 45-49, 50-59 and 60-69 will be given, thus allowing improvements to be made if necessary.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander F. E., Roberts M. M., Huggins A., Muir B. B. Use of risk factors to allocate schedules for breast cancer screening. J Epidemiol Community Health. 1988 Jun;42(2):193–199. doi: 10.1136/jech.42.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beahrs O. H., Smart C. R. Diagnosis of minimal breast cancers in the BCDDP: the 66 questionable cases. Cancer. 1979 Mar;43(3):848–850. doi: 10.1002/1097-0142(197903)43:3<848::aid-cncr2820430310>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Brecht J. G., Robra B. P. A graphic method of estimating the specificity of screening programmes from incomplete follow-up data. Methods Inf Med. 1987 Jan;26(1):53–58. [PubMed] [Google Scholar]
  4. Chamberlain J., Clifford R. E., Nathan B. E., Price J. L., Burn I. Repeated screening for breast cancer. J Epidemiol Community Health. 1984 Mar;38(1):54–57. doi: 10.1136/jech.38.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Day N. E., Williams D. R., Khaw K. T. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989 Jun;59(6):954–958. doi: 10.1038/bjc.1989.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Elston C. W. Pathological aspects of the UK Breast Screening Project with special reference to minimal and 'borderline' lesions. Aust N Z J Surg. 1984 Jun;54(3):201–204. doi: 10.1111/j.1445-2197.1984.tb05302.x. [DOI] [PubMed] [Google Scholar]
  7. Knox E. G. Evaluation of a proposed breast cancer screening regimen. BMJ. 1988 Sep 10;297(6649):650–654. doi: 10.1136/bmj.297.6649.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Peeters P. H., Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Vooijs G. P. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer. 1989 Jun;59(6):929–932. doi: 10.1038/bjc.1989.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Peeters P. H., Verbeek A. L., Hendriks J. H., van Bon M. J. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986. Int J Cancer. 1989 Feb 15;43(2):226–230. doi: 10.1002/ijc.2910430209. [DOI] [PubMed] [Google Scholar]
  10. Peeters P. H., Verbeek A. L., Straatman H., Holland R., Hendriks J. H., Mravunac M., Rothengatter C., Van Dijk-Milatz A., Werre J. M. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol. 1989 Jun;18(2):295–299. doi: 10.1093/ije/18.2.295. [DOI] [PubMed] [Google Scholar]
  11. Tabar L., Fagerberg G., Duffy S. W., Day N. E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 1989 Jun;43(2):107–114. doi: 10.1136/jech.43.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Witcombe J. B. A licence for breast cancer screening? Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):909–911. doi: 10.1136/bmj.296.6626.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van der Maas P. J., de Koning H. J., van Ineveld B. M., van Oortmarssen G. J., Habbema J. D., Lubbe K. T., Geerts A. T., Collette H. J., Verbeek A. L., Hendriks J. H. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989 Jun 15;43(6):1055–1060. doi: 10.1002/ijc.2910430617. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES